期 |
栏目 |
标题 |
文件 |
卷 81, 编号 7 (2009) |
Editorial |
Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in subleukemic myelosis and congenital immunodeficiency |
|
卷 90, 编号 8 (2018) |
Editorial |
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 90, 编号 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 90, 编号 8 (2018) |
Editorial |
Differential diagnosis of ascites in internal medicine: clinical case |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 91, 编号 2 (2019) |
Editorial |
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study |
![PDF](/img/labels/pdf.png) (Rus)
![PDF](/img/labels/pdf.png) (Eng)
|
卷 91, 编号 2 (2019) |
Editorial |
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 92, 编号 3 (2020) |
Editorial |
Changes in gut microbiota with bronchial asthma |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 92, 编号 4 (2020) |
Original articles |
Rebamipide using in gastroesophageal reflux disease treatment |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 94, 编号 2 (2022) |
Consensuns |
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 11 (2021) |
Original articles |
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis |
![PDF](/img/labels/pdf.png) (Rus)
|